Phaedra Chrousos - 05 Jun 2025 Form 4 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Role: Director
Signature: /s/ Phaedra Chrousos
Issuer symbol: VNDA
Transactions as of: 05 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 09 Jun 2025, 17:35:49 UTC
Previous filing: 24 May 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Chrousos Phaedra	Director	C/O VANDA PHARMACEUTICALS INC., 2200 PENNSYLVANIA AVENUE, SUITE 300E, WASHINGTON	/s/ Phaedra Chrousos	09 Jun 2025	0001774518

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VNDA	Common Stock	Award	$0	+59,225	+92%	$0.000000	123,350	05 Jun 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 5, 2026, provided that the Reporting Person has provided continuous service to the Issuer through the vesting date.